News & Updates

Back to All News

Lankenau Medical Center urologist performing new life-changing laser procedure for post-menopausal women

Lankenau Medical Center November 11, 2015 News Releases

A new laser treatment is now being performed at Lankenau Medical Center, part of Main Line Health, to reverse the effects of vaginal atrophy, a conditioned experienced by millions of post-menopausal women due to age and certain medical treatments. Darlene Gaynor, DO, Female Urology/Pelvic Medicine, is using a laser, called MonaLisa Touch®, to improve blood flow to the vaginal tissue and regenerate vaginal cells to stimulate collagen to improve dryness. Many women are also noticing relief of burning, as well as urinary urgency and frequency.

“The MonaLisa Touch is a game changer for women who suffer from vaginal atrophy due to menopause or for women who have a drop in estrogen levels because of breast cancer,” said Dr. Gaynor. “Symptoms like mood swings, weight gain and hot flashes have become synonymous with menopause. They aren’t painful. But others like burning, itching and redness can be. I am pleased to be able to offer this to patients here at Lankenau as a way to restore women’s sex lives and daily gynecologic health.”

The standard treatment for this condition has always been hormone replacement or estrogen creams, but those come with side effects. Recently approved by the Food and Drug Administration, the MonaLisa Touch laser procedure is performed in the physician’s office with no anesthesia. During the procedure, the laser, a vaginal probe, is inserted into the vagina and delivers a series of gentle laser energy pulses. These pulses are painless for most patients, though some women may experience mild discomfort as a result of vaginal dryness.

“The procedure takes five minutes to complete and women are advised to receive three treatments over the course of 18 weeks,” explained Dr. Gaynor. “The results vary woman to woman, but most notice their symptoms getting better after the first or second treatment. After the first year, women should return for a follow up treatment.”

To learn more about the MonaLisa Touch procedure, the community is welcome to attend a seminar presented by Dr. Gaynor, “Restoring Gynecologic Health: New Life-Changing Treatment for Post-Menopausal Women,” on Tuesday, November 17, 2015, 6:00–7:00 pm at Lankenau Medical Center, Medical Office Building East, Suite 361, 100 East Lancaster Avenue, Wynnewood, Pa. To register, or for more information about the treatment, call 610.649.6420.

About Lankenau Medical Center

Lankenau Medical Center, a member of Main Line Health, is recognized as a national leader in advancing new options to diagnose and treat illness, protect against disease and save lives. Located on a 93-acre campus just outside of Philadelphia, Lankenau Medical Center is a 389-bed, not-for-profit teaching hospital that includes one of the nation’s leading cardiovascular centers; the Lankenau Institute for Medical Research, one of the few freestanding hospital-associated research centers in the nation; and the Annenberg Conference Center for Medical Education, that trains over 100 new physicians each year through nationally ranked residency and fellowship programs. Lankenau has received both regional and national recognition for its excellence in providing state-of-the-art, quality care. Lankenau Medical Center has been named among the top 10 hospitals in Pennsylvania and top five in the Philadelphia metro area in U.S. News & World Report’s Best Hospitals 2016–17, and was ranked as high-performing in four specialties: gastroenterology & GI surgery, geriatrics, orthopedics and pulmonology. Lankenau was also ranked as high performing in all nine of the Common Core specialty areas that the publication analyzes, including: abdominal aortic aneurysm repair, aortic valve surgery, COPD, colon cancer surgery, congestive heart failure, heart bypass surgery, hip replacement, knee replacement and lung cancer surgery. Lankenau has achieved The Joint Commission’s Gold Seal of Approval for stroke care and breast cancer care and is one of the nation’s Top Performing Hospitals for heart attack, heart failure, pneumonia and surgical care. Lankenau has also been ranked for multiple years as one of the top 50 cardiovascular hospitals in the nation by Truven Health Analytics. Lankenau has also earned the highest distinction for excellence in nursing care, the American Nurses Credentialing Center Magnet® designation.


Bridget Therriault
Director, Communications
Office: 484.580.1025
Cell: 484.222.9154